JC Timmerman, WW Schmitt, RA Widenhoefer
文献索引:Scott, James S.; Gill, Adrian L.; Godfrey, Linda; Groombridge, Sam D.; Rees, Amanda; Revill, John; Schofield, Paul; Soerme, Pernilla; Stocker, Andrew; Swales, John G.; Whittamore, Paul R.O. Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 21 p. 6756 - 6761
全文:HTML全文
被引用次数: 0
... Table c (IPr)AuOTf employed as catalyst at 40 °C for 18 h. Table d Reaction conditions: 1a (2 mmol), 2a (2.4 mmol), and (IPr)AuOTf (4 mol %) at 40 °C for 32 h. Table e [(IPr)Au(NCPh)] + SbF 6 – employed as catalyst at 25 °C for 48 h. ...
78318-44-2
4-甲基-2-吗啉嘧啶-5-羧酸乙酯
~%
873450-22-7
4-甲基-2-吗啉-4-嘧啶-5-羧酸
134653-70-6
2-Dimethylamino...
87-13-8
乙氧甲叉
463-52-5
formamidine
4786-52-1
4-羟基-5-嘧啶甲酸乙酯
862695-74-7
6-chloro-2-cycl...
~99%
862695-75-8
6-氯-2-环丙基烟酸
32249-35-7
3-环丙基-3-氧代丙酸甲酯
862695-71-4
3-amino-3-cyclo...
862695-72-5
4-(1-amino-1-cy...
862695-73-6
2-cyclopropyl-6...
727383-48-4
2-(环丙烷羰基)-3-(二甲...
124-42-5
乙脒盐酸盐
887410-59-5
Ethyl 4-cyclopr...
24922-02-9
3-环丙基-3-氧代丙酸乙酯